|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|

|
|
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
(
|
|
(Registrant’s Telephone Number, Including Area Code)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||
|
|
|
|
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
|
|
Smaller reporting company
|
|
Emerging growth company
|
|
PART I.
|
||
|
Item 1.
|
2
|
|
|
Item 1A.
|
6
|
|
|
Item 1B.
|
19
|
|
|
Item 1C.
|
19
|
|
|
Item 2.
|
20
|
|
|
Item 3.
|
20 | |
|
Item 4.
|
20
|
|
|
PART II.
|
||
|
Item 5.
|
21
|
|
|
Item 6.
|
21
|
|
|
Item 7.
|
21
|
|
|
Item 7A.
|
29
|
|
|
Item 8.
|
29
|
|
|
Item 9.
|
29
|
|
|
Item 9A.
|
29
|
|
|
Item 9B.
|
29
|
|
|
Item 9C.
|
29
|
|
|
PART III.
|
||
|
Item 10.
|
30
|
|
|
Item 11.
|
30
|
|
|
Item 12.
|
30
|
|
|
Item 13.
|
30
|
|
|
Item 14.
|
30
|
|
|
PART IV.
|
||
|
Item 15.
|
31
|
|
|
Item 16.
|
33
|
|
| 34 |
||
|
CONSOLIDATED FINANCIAL STATEMENTS
|
||
|
F-1
|
||
| • |
the adverse effects of current economic conditions on our business, operations, financial condition, results of operations and capital resources;
|
| • |
our ability to achieve the anticipated benefits of our acquisition of a licensed copy of the source code for the BOHA! software and risks to our
reputation and business relating to the source code transition;
|
| • |
our ability to successfully transition the BOHA! source code to our platform and systems and, until such transition is complete, our continued
reliance on third parties to host and support our FST offerings;
|
| • |
difficulties or delays in manufacturing or delivery of inventory or other supply chain disruptions;
|
| • |
our dependence on a single contract manufacturer for the assembly of a large portion of our products in Asia;
|
| • |
the imposition of additional duties, tariffs, quotas, taxes, trade barriers, capital flow restrictions and other charges on imports and exports by
the United States or the governments of the countries in which we or our manufacturers and suppliers operate including the potential for new or reinstated trade measures following the U.S. Supreme Court’s decision to invalidate certain
previously imposed tariffs;
|
| • |
the Russia/Ukraine and Middle East conflicts;
|
| • |
inadequate manufacturing capacity or a shortfall or excess of inventory as a result of difficulty in predicting manufacturing requirements due to
volatile economic conditions;
|
| • |
price increases, decreased availability of third-party component parts or raw materials at reasonable prices, price wars or significant pricing
pressures affecting the Company’s products in the United States or abroad;
|
| • |
increased product costs or reduced customer demand for our products in the United States or abroad, including as a result of trade wars, tariffs or
other trade actions;
|
| • |
our ability to successfully develop new products that garner customer acceptance and generate sales, both domestically and internationally, in the
face of substantial competition;
|
| • |
any system outages, interruptions or other disruptions to our software applications, including as a result of unexpected errors or mistakes in
connection with over-the-air updates;
|
| • |
our ability to successfully grow our business in the food service technology market;
|
| • |
renewal rates for our subscription-based products;
|
| • |
risks associated with the pursuit of strategic initiatives and business growth;
|
| • |
our dependence on significant suppliers;
|
| • |
our ability to recruit and retain quality employees;
|
| • |
our dependence on third parties for sales outside the United States;
|
| • |
marketplace acceptance of new products;
|
| • |
risks associated with foreign operations;
|
| • |
political and policy uncertainties, and any adverse economic impacts resulting from such uncertainties;
|
| • |
our ability to protect intellectual property;
|
| • |
exchange rate fluctuations;
|
| • |
the availability of needed financing on acceptable terms or at all;
|
| • |
volatility of, and decreases in, trading prices of our common stock; and
|
| • |
other risk factors identified and discussed in Part I, Item 1A, Risk Factors, and Part II, Item 7, Management’s Discussion and Analysis of Financial
Condition and Results of Operations, of this Form 10-K and that may be detailed from time to time in the Company’s other reports filed with the Securities and Exchange Commission (the “SEC”).
|
|
Name
|
Age
|
Position
|
||
|
John M. Dillon
|
76
|
Chief Executive Officer
|
||
|
Steven A. DeMartino
|
56
|
President, Chief Financial Officer, Treasurer and Secretary
|
||
|
Tracey S. Winslow
|
66
|
Chief Revenue Officer
|
||
|
Brent W. Richtsmeier
|
61
|
Chief Technology Officer
|
||
|
Dana Loof
|
59
|
Chief Marketing Officer
|
||
|
William J. DeFrances
|
61
|
Vice President & Chief Accounting Officer
|
| • |
delays between our expenditures to develop and market new or enhanced products and consumables and the generation of sales from those products;
|
| • |
the geographic distribution of our sales and our supply chain;
|
| • |
market acceptance of our products, both domestically and internationally;
|
| • |
development of new competitive products by others;
|
| • |
increased levels of competition, including due to increased levels of competition in the POS automation market;
|
| • |
our responses to price competition;
|
| • |
our level of research and development activities;
|
| • |
changes in the amount that we spend to develop, acquire or license new products, consumables, technologies or businesses, including costs associated with the recent
acquisition of a licensed copy of the BOHA! source code;
|
| • |
changes in the amount we spend to promote our products and services;
|
| • |
changes in the cost of satisfying our warranty obligations and servicing our installed base of products;
|
| • |
availability of third-party components at reasonable prices or at all;
|
| • |
general economic and industry conditions, including inflation and changes in interest rates affecting returns on cash balances, investments and debt, that affect
customer demand;
|
| • |
changes in customer demand due to supply chain constraints;
|
| • |
the dependence of our supply chain on a few, foreign third party manufacturers and suppliers and the impact on our supply chain of product or component shortages and
cost increases due to events beyond our control, including tariffs and other trade policies, inflation and political or social instability such as the ongoing Russia/Ukraine war, conflicts in the Middle East, and tensions between China and
Taiwan and possible expansion of such war, conflicts or tensions;
|
| • |
severe weather events, public health crises, military actions, the cost of insurance and other external events out of our control that can disrupt our operations or the
operations of our customers’ or suppliers’ facilities; and
|
| • |
changes in accounting rules and regulations.
|
| • |
loss of channel and the ability to bring new products to market;
|
| • |
concentration of credit risk, including disruption in distribution should the distributors, and / or resellers’ financial condition deteriorate;
|
| • |
reduced visibility to end user demand and pricing issues which makes forecasting more difficult;
|
| • |
distributors or resellers leveraging their buying power to change the terms of pricing, payment and product delivery schedules; and
|
| • |
direct competition should a distributor or reseller decide to manufacture printers internally or source printers from a competitor.
|
| • |
technologically advanced products that satisfy user demands;
|
| • |
superior customer service;
|
| • |
high levels of quality and reliability; and
|
| • |
dependable and efficient distribution networks.
|
| • |
accurately forecast our revenue and plan our operating expenses;
|
| • |
increase the number of customers (and retain existing customers and their guests) using our platform;
|
| • |
successfully compete with current and future competitors;
|
| • |
successfully expand our market presence in existing markets and enter new markets and geographies;
|
| • |
maintain and enhance the value of our reputation and brand;
|
| • |
develop and maintain strategic relationships with other market participants that provide complementary products;
|
| • |
adapt to rapidly evolving trends in the ways our customers interact with technology, including through the use of emerging artificial intelligence and machine learning
technologies;
|
| • |
timely respond to customer needs with technology developments that enable our products to evolve to meet the changing demands of the marketplace;
|
| • |
avoid interruptions or disruptions in our service; and
|
| • |
manage the risk of loss relating to food safety issues if there is a failure of our offerings designed to help in part to assure perishable goods are safely preserved.
|
| • |
the imposition of additional duties, tariffs, quotas, taxes, trade barriers, capital flow restrictions and other charges on imports and exports by the United States or
the governments of the countries in which we or our manufacturers and suppliers operate;
|
| • |
delays in the delivery of cargo due to port security considerations, labor disputes such as dock strikes, and our reliance on a limited number of shipping and air
carriers, which may experience capacity issues that adversely affect our ability to ship inventory in a timely manner or for an acceptable cost;
|
| • |
fluctuations in the value of the U.S. dollar against foreign currencies, which could restrict sales, or increase costs of purchasing, in foreign countries;
|
| • |
economic or political instability in any of the countries in which we or our manufacturers or suppliers operate, which could result in a reduction in demand for our
products or impair our foreign assets;
|
| • |
a reduced ability or inability to sell in or purchase from certain markets as a result of export or import restrictions;
|
| • |
potentially limited intellectual property protection in certain countries, such as China, may limit recourse against infringing products or cause us to refrain from
selling in certain geographic territories;
|
| • |
difficulties staffing and managing foreign operations; and
|
| • |
economic uncertainties and adverse economic conditions (including inflation and recession).
|
| • |
merge, consolidate, form subsidiaries or dispose of assets;
|
| • |
acquire assets outside the ordinary course of business;
|
| • |
enter into other transactions outside the ordinary course of business;
|
| • |
sell, transfer, return or dispose of collateral;
|
| • |
make loans to, or investments in, or enter into transactions with, affiliates;
|
| • |
incur or guarantee indebtedness, incur liens;
|
| • |
redeem equity interests while borrowings are outstanding under the credit facility;
|
| • |
change our capital structure; or
|
| • |
dissolve, divide, change our line of business or cease or suffer a disruption to all or a material portion of our business.
|
| • |
prevailing domestic and international market and economic conditions, and conditions in the industries we serve, including current market volatility, inflation and
pressures resulting from tariffs and other trade actions;
|
| • |
adverse business conditions faced by customers, or bankruptcies or store closures of our customers resulting from adverse economic conditions;
|
| • |
changes in our business, operations or prospects;
|
| • |
developments in our relationships with our customers or strategic partners;
|
| • |
announcements of new products or services by us or by our competitors;
|
| • |
announcement or completion of acquisitions by us or by our competitors;
|
| • |
changes in existing, or adoption of additional, government regulations;
|
| • |
developments or announcements with respect to our strategic review process and the pace of progress with respect to that process, and
|
| • |
unfavorable or reduced analyst coverage.
|
| • |
Governance: As discussed in more detail below under the heading “Governance,” the Board of Directors’ oversight of cybersecurity risk management is supported by the Audit Committee of the
Board of Directors (the “Audit Committee”), which regularly interacts with the Company’s ERM function, the Company’s Vice President of Information Technology, other members of management and relevant management committees and councils,
including management’s Sarbanes-Oxley & Cybersecurity Steering Committee.
|
| • |
Collaborative Approach: The Company has implemented a comprehensive, cross-functional approach to identifying, preventing and mitigating cybersecurity threats and incidents, while also
implementing controls and procedures that are designed to provide for the prompt and appropriate internal reporting of certain cybersecurity incidents, either in the form of a single unauthorized occurrence or a series of unauthorized
occurrences, so that decisions regarding the public disclosure and reporting of such incidents can be made by management in a timely manner.
|
| • |
Technical Safeguards: The Company deploys technical safeguards that are designed to protect the Company’s information systems from cybersecurity threats, including firewalls, intrusion
prevention and detection systems, anti-malware functionality and access controls, which are evaluated and improved through vulnerability assessments and cybersecurity threat intelligence.
|
| • |
Incidence Response and Recovery Planning: The Company has established and maintains comprehensive incident response and recovery plans intended to fully and timely address the Company’s
response to a cybersecurity incident, and such plans are tested and evaluated on a regular basis.
|
| • |
|
| • |
Education and Awareness: The Company provides regular, mandatory training for personnel regarding cybersecurity threats as a means to equip the Company’s personnel with effective tools to
proactively address cybersecurity threats and prevent incursions and to communicate the Company’s evolving information security policies, standards, processes and practices. Our awareness program includes assessment of our personnel’s
preparedness through regular phishing e-mail alerts, highlighted banners that warn about external senders, and tests administered to help the Company’s personnel interrogate, navigate around, and avoid clicking suspicious and unfamiliar
links from unknown senders.
|
|
Location
|
Operations Conducted
|
Size
(Approx. Sq. Ft.)
|
Owned
or Leased
|
Lease
Expiration Date
|
|||||
|
Hamden, Connecticut
|
Executive offices
|
3,630
|
Leased
|
December 31, 2029
|
|||||
|
Ithaca, New York
|
Hardware design and development, assembly and service facility
|
73,900
|
Leased
|
May 31, 2026
|
|||||
|
Las Vegas, Nevada
|
Software design and development and casino and gaming sales office
|
9,400
|
Leased
|
June 30, 2031
|
|||||
|
Doncaster, UK
|
Sales office and service center
|
6,000
|
Leased
|
August 24, 2026
|
|||||
|
Macau, China
|
Sales office
|
180
|
Leased
|
April 30, 2026
|
|||||
|
93,110
|
|||||||||
|
Year Ended
|
Year Ended
|
|||||||||||||||||||||||
|
(In thousands, except percentages)
|
December 31, 2025
|
December 31, 2024
|
$ Change
|
% Change
|
||||||||||||||||||||
|
FST
|
$
|
19,318
|
37.5
|
%
|
$
|
16,101
|
37.1
|
%
|
$
|
3,217
|
20.0
|
%
|
||||||||||||
|
POS automation
|
2,213
|
4.3
|
%
|
3,361
|
7.8
|
%
|
(1,148
|
)
|
(34.2
|
%)
|
||||||||||||||
|
Casino and gaming
|
26,873
|
52.2
|
%
|
20,348
|
46.9
|
%
|
6,525
|
32.1
|
%
|
|||||||||||||||
|
TSG
|
3,076
|
6.0
|
%
|
3,574
|
8.2
|
%
|
(498
|
)
|
(13.9
|
%)
|
||||||||||||||
|
$
|
51,480
|
100.0
|
%
|
$
|
43,384
|
100.0
|
%
|
$
|
8,096
|
18.7
|
%
|
|||||||||||||
|
International*
|
$
|
9,365
|
18.2
|
%
|
$
|
9,899
|
22.8
|
%
|
$
|
(534
|
)
|
(5.4
|
%)
|
|||||||||||
| * |
International sales do not include sales of products to domestic distributors or other customers who in turn ship those products to international destinations.
|
|
Year Ended
|
Year Ended
|
|||||||||||||||||||||||
|
(In thousands, except percentages)
|
December 31, 2025
|
December 31, 2024
|
$ Change
|
% Change
|
||||||||||||||||||||
|
Domestic
|
$
|
17,886
|
92.6
|
%
|
$
|
14,719
|
91.4
|
%
|
$
|
3,167
|
21.5
|
%
|
||||||||||||
|
International
|
1,432
|
7.4
|
%
|
1,382
|
8.6
|
%
|
50
|
3.6
|
%
|
|||||||||||||||
|
$
|
19,318
|
100.0
|
%
|
$
|
16,101
|
100.0
|
%
|
$
|
3,217
|
20.0
|
%
|
|||||||||||||
|
Year Ended
|
Year Ended
|
|||||||||||||||||||||||
|
(In thousands, except percentages)
|
December 31, 2025
|
December 31, 2024
|
$ Change
|
% Change
|
||||||||||||||||||||
|
Hardware
|
$
|
7,076
|
36.6
|
%
|
$
|
5,319
|
33.0
|
%
|
$
|
1,757
|
33.0
|
%
|
||||||||||||
|
Software, labels and other recurring revenue
|
12,242
|
63.4
|
%
|
10,782
|
67.0
|
%
|
1,460
|
13.5
|
%
|
|||||||||||||||
|
$
|
19,318
|
100.0
|
%
|
$
|
16,101
|
100.0
|
%
|
$
|
3,217
|
20.0
|
%
|
|||||||||||||
|
Year Ended
|
Year Ended
|
|||||||||||||||||||||||
|
(In thousands, except percentages)
|
December 31, 2025
|
December 31, 2024
|
$ Change
|
% Change
|
||||||||||||||||||||
|
Domestic
|
$
|
2,208
|
99.8
|
%
|
$
|
3,361
|
100.0
|
%
|
$
|
(1,153
|
)
|
(34.3
|
%)
|
|||||||||||
|
International
|
5
|
0.2
|
%
|
–
|
–
|
5
|
N/A
|
|||||||||||||||||
|
$
|
2,213
|
100.0
|
%
|
$
|
3,361
|
100.0
|
%
|
$
|
(1,148
|
)
|
(34.2
|
%)
|
||||||||||||
|
Year Ended
|
Year Ended
|
|||||||||||||||||||||||
|
(In thousands, except percentages)
|
December 31, 2025
|
December 31, 2024
|
$ Change
|
% Change
|
||||||||||||||||||||
|
Domestic
|
$
|
19,586
|
72.9
|
%
|
$
|
12,522
|
61.5
|
%
|
$
|
7,064
|
56.4
|
%
|
||||||||||||
|
International
|
7,287
|
27.1
|
%
|
7,826
|
38.5
|
%
|
(539
|
)
|
(6.9
|
%)
|
||||||||||||||
|
$
|
26,873
|
100.0
|
%
|
$
|
20,348
|
100.0
|
%
|
$
|
6,525
|
32.1
|
%
|
|||||||||||||
|
Year Ended
|
Year Ended
|
|||||||||||||||||||||||
|
(In thousands, except percentages)
|
December 31, 2025
|
December 31, 2024
|
$ Change
|
% Change
|
||||||||||||||||||||
|
Domestic
|
$
|
2,435
|
79.2
|
%
|
$
|
2,883
|
80.7
|
%
|
$
|
(448
|
)
|
(15.5
|
%)
|
|||||||||||
|
International
|
641
|
20.8
|
%
|
691
|
19.3
|
%
|
(50
|
)
|
(7.2
|
%)
|
||||||||||||||
|
$
|
3,076
|
100.0
|
%
|
$
|
3,574
|
100.0
|
%
|
$
|
(498
|
)
|
(13.9
|
%)
|
||||||||||||
|
Year Ended December 31,
|
Percent
|
Percent of
|
Percent of
|
|||||||||||||||
|
2025
|
2024
|
Change
|
Total Sales - 2025
|
Total Sales - 2024
|
||||||||||||||
|
$
|
25,015
|
$
|
21,482
|
16.4
|
%
|
48.6
|
%
|
49.5
|
%
|
|||||||||
|
Year Ended December 31,
|
Percent
|
Percent of
|
Percent of
|
|||||||||||||||
|
2025
|
2024
|
Change
|
Total Sales - 2025
|
Total Sales - 2024
|
||||||||||||||
|
$
|
6,701
|
$
|
6,977
|
(4.0
|
%)
|
13.0
|
%
|
16.1
|
%
|
|||||||||
|
Year Ended December 31,
|
Percent
|
Percent of
|
Percent of
|
|||||||||||||||
|
2025
|
2024
|
Change
|
Total Sales - 2025
|
Total Sales - 2024
|
||||||||||||||
|
$
|
8,433
|
$
|
8,195
|
2.9
|
%
|
16.4
|
%
|
18.9
|
%
|
|||||||||
|
Year Ended December 31,
|
Percent
|
Percent of
|
Percent of
|
|||||||||||||||
|
2025
|
2024
|
Change
|
Total Sales - 2025
|
Total Sales - 2024
|
||||||||||||||
|
$
|
11,296
|
$
|
9,936
|
13.7
|
%
|
21.9
|
%
|
22.9
|
%
|
|||||||||
|
Year Ended December 31,
|
Percent
|
Percent of
|
Percent of
|
|||||||||||||||
|
2025
|
2024
|
Change
|
Total Sales – 2025
|
Total Sales – 2024
|
||||||||||||||
|
$
|
(1,415
|
)
|
$
|
(3,626
|
)
|
61.0
|
%
|
(2.7
|
%)
|
(8.4
|
%)
|
|||||||
| • |
We reported a net loss of $1.2 million.
|
|
|
•
|
We recorded depreciation and amortization of $0.7 million and share-based compensation expense of $1.8 million.
|
| • |
Inventory decreased $5.4 million despite higher sales in 2025 due to an inventory reduction program we put into place in the latter part of 2024.
|
| • |
Accrued liabilities and other liabilities increased $1.9 million due primarily to an increase in our employee bonus accrual.
|
| • |
Accounts payable decreased $1.0 million due to a reduction in inventory purchases and the timing of cash disbursements.
|
| • |
We reported a net loss of $9.9 million.
|
|
|
•
|
We recorded depreciation and amortization of $1.0 million and share-based compensation expense of $1.2 million.
|
| • |
We recorded a decrease in our net deferred tax assets of $6.3 million due to an
income tax charge of $7.3 million related to the write down of our U.S. net deferred income tax asset.
|
| • |
Accounts receivable decreased $3.3 million primarily due to lower sales volume in 2024.
|
| • |
Inventories decreased $1.6 million primarily due to lower sales volume in 2024.
|
|
|
•
|
Accrued liabilities and other liabilities decreased $1.8 million due to lower employee bonus and payroll accruals in 2024 compared to
2023.
|
| (a) |
None
|
| (b) |
During the fourth quarter of 2025, no director or officer of the Company
|
|
Plan category
|
(a)
Number of
securities to be
issued upon exercise
of outstanding
options, warrants
and rights
|
(b)
Weighted-
average
exercise price
of outstanding
options, warrants
and rights
|
(c)
Number of securities
remaining available for
future issuance under
equity compensation plans
(excluding securities
reflected in column (a)
|
|||||||||
|
Equity compensation plans approved by security holders:
|
||||||||||||
|
2014 Equity Incentive Plan
|
1,302,870
|
$ |
8.03
|
1,002,690
|
||||||||
|
Total
|
1,302,870
|
$
|
8.03
|
1,002,690
|
||||||||
| (a) |
The following documents are filed as part of this Form 10-K:
|
| 1. |
Financial Statements.
|
|
Reports of Independent Registered Public Accounting Firms
|
|
Consolidated Balance Sheets as of December 31, 2025 and 2024
|
|
Consolidated Statements of Operations for the years ended December 31, 2025 and 2024
|
|
Consolidated Statements of Comprehensive Loss for the years ended December 31, 2025 and 2024
|
|
Consolidated Statements of Changes in Shareholders’ Equity for the years ended December 31, 2025 and 2024
|
|
Consolidated Statements of Cash Flows for the years ended December 31, 2025 and 2024
|
|
Notes to Consolidated Financial Statements
|
| 2. |
Schedules.
|
| 3. |
Exhibits
|
|
Certificate of Incorporation of TransAct Technologies Incorporated (conformed copy) (incorporated by reference to Exhibit 3.2 of the Company’s
Quarterly Report on Form 10-Q (SEC File No. 000-21121) filed with the SEC on August 18, 2022).
|
|
|
Certificate of Designation, Series A Preferred Stock, filed with the
Secretary of State of Delaware on December 2, 1997 (incorporated by reference to Exhibit C of the Form of Amended and Restated Rights Agreement, dated as of February 16, 1999, between TransAct Technologies Incorporated and American
Stock Transfer & Trust Company filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K (SEC File No. 000-21121) filed with the SEC on February 18, 1999).
|
|
|
Certificate of Designation, Series B Preferred Stock, filed with the Secretary of State of Delaware on April 6, 2000 (incorporated by reference to
Exhibit 3.1(c) of the Company’s Quarterly Report on Form 10-Q (SEC File No. 000-21121) filed with the SEC on May 8, 2000).
|
|
|
3.2*
|
Amended and Restated By-Laws of TransAct Technologies Incorporated (as of February 25, 2026).
|
|
Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 of the Company’s Registration Statement on Form S-1/A (No. 333-06895)
filed with the SEC on August 1, 1996).
|
|
|
Description of Securities (incorporated by reference to Exhibit 4.2 of the Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with
the SEC on March 13, 2024).
|
|
|
10.1(x)
|
2005 Equity Incentive Plan (incorporated by reference to Exhibit 99.1 of the Company’s Current Report on Form 8-K (SEC File No. 000-21121) filed
with the SEC on June 1, 2005).
|
|
10.2(x)
|
TransAct Technologies Incorporated 2014 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form
8-K (SEC File No. 000-21121) filed with the SEC on May 19, 2014).
|
|
10.3(x)
|
Amendment to 2014 Equity Incentive Plan approved by Shareholders on May 22, 2017 (incorporated by reference to Exhibit 10.1 of the Company’s
Quarterly Report on Form 10-Q (SEC File No. 000-21121) filed with the SEC on August 9, 2017).
|
|
10.4(x)
|
TransAct Technologies Incorporated 2014 Equity Incentive Plan, as Amended and Restated in 2020 (incorporated by reference to Exhibit I to the
Definitive Proxy Statement on Schedule 14A filed with the Commission on April 23, 2020, File No. 000-21121).
|
|
10.5(x)
|
TransAct Technologies Incorporated 2014 Equity Incentive Plan, as Amended and Restated in 2023 (incorporated by reference to Exhibit I to the
Definitive Proxy Statement on Schedule 14A filed with the Commission on April 21, 2023, File No. 000-21121).
|
|
10.6(x)
|
2014 Equity Incentive Plan Time-based Restricted Stock Unit Agreement (incorporated by reference to Exhibit 10.2 of the Company’s Quarterly Report
on Form 10-Q (SEC File No. 000-21121) filed with the SEC on May 6, 2016).
|
|
10.7(x)
|
2014 Equity Incentive Plan Performance-based Restricted Stock Unit Agreement (incorporated by reference to Exhibit 10.1 of the Company’s Quarterly
Report on Form 10-Q (SEC File No. 000-211121) filed with the SEC on August 8, 2016).
|
|
10.8(x)
|
2014 Equity Incentive Plan Non-statutory Stock Option Agreement (incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form
8-K (SEC File No. 000-21121) filed with the SEC on May 19, 2014).
|
|
10.10(x)
|
Severance Agreement by and between TransAct Technologies Incorporated and Brent Richtsmeier, dated as of January 1, 2021 (incorporated by reference
to Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q (SEC File No. 000-21121) filed with the SEC on May 15, 2023).
|
|
10.11(x)
|
Severance Agreement by and between TransAct and Tracey S. Winslow, dated as of December 22, 2023 (incorporated by reference to Exhibit 10.11 to the
Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 24, 2025).
|
|
10.12(x)
|
Severance Agreement by and between TransAct and William J. DeFrances, dated as of August 3, 2022 (incorporated by reference to Exhibit 10.12 to the
Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 24, 2025).
|
|
10.13(x)
|
Executive Employment Agreement by and between TransAct Technologies Incorporated and John M. Dillon, dated as of September 4, 2024 (incorporated by
reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (SEC File No. 000-21121) filed with the SEC on September 6, 2024).
|
|
10.14(x)
|
Executive Employment Agreement by and between TransAct Technologies Incorporated and Steven A. DeMartino, dated as of September 4, 2024
(incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K (SEC File No. 000-21121) filed with the SEC on September 6, 2024).
|
|
Lease Agreement between Bomax Properties, LLC and TransAct, dated July 18, 2001 (incorporated by reference to Exhibit 10.16 to the Company’s Annual
Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 13, 2024).
|
|
|
Amendment No. 1 to Lease Agreement between Bomax Properties, LLC and TransAct, dated May 8, 2012 (incorporated by reference to Exhibit 10.16 of the
Company’s Quarterly Report on Form 10-Q (SEC File No. 000-21121) filed with the SEC on May 10, 2012).
|
|
|
Amendment No. 2 to Lease Agreement between Bomax Properties, LLC and TransAct, dated January 14, 2016 (incorporated by reference to Exhibit 10.13
of the Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 11, 2016).
|
|
|
Amendment No. 3 to Lease Agreement between Bomax Properties, LLC and TransAct, dated February 29, 2020 (incorporated by reference to Exhibit 10.1
to the Company’s Current Report on Form 8-K (SEC File No. 000-21121) filed with the SEC on March 4, 2020).
|
|
|
Amendment No. 4 to Lease Agreement between Bomax Properties, LLC and TransAct, dated July 15, 2022 (incorporated by reference to Exhibit 10.19 to
the Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 24, 2025).
|
|
|
Amendment No. 5 to Lease Agreement between Bomax Properties, LLC and TransAct, dated May 31, 2024 (incorporated by reference to Exhibit 10.1 to the
Company’s Quarterly Report on Form 10-Q (SEC File No. 000-21121) filed with the SEC on August 9, 2024).
|
|
|
Lease Agreement by and between 2319 Hamden Center I, L.L.C. and TransAct dated November 27, 2006 (incorporated by reference to Exhibit 10.14 of the
Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 15, 2007).
|
|
|
First Amendment to Lease by and between 2319 Hamden Center I, L.L.C. and TransAct dated January 3, 2017 (incorporated by reference to Exhibit 10.20
of the Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 16, 2017).
|
|
|
Second Amendment to Lease by and between 2319 Hamden Center I, L.L.C. and TransAct Technologies dated April 30, 2021 (incorporated by reference to
Exhibit 10.1 of the Company’s Quarterly Report on Form 10-Q (SEC File No. 000-21121) filed with the SEC on May 13, 2021).
|
|
|
Third Amendment to Lease, dated as of November 3, 2025, by and between One Hamden Center, LLC and TransAct Technologies Incorporated (incorporated
by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K (SEC File No. 000-21121) filed with the SEC on November 7, 2025).
|
|
|
Loan and Security Agreement, dated as of March 13, 2020, among Siena Lending Group LLC, TransAct Technologies Incorporated and the other Loan
Parties from time to time party thereto (incorporated by reference to Exhibit 10.2 of the Company’s Quarterly Report on Form 10-Q (SEC File No. 000-21121) filed with the SEC on May 22, 2020).
|
|
|
Amendment No. 1 To Loan and Security Agreement, dated as of July 21, 2021, among Siena Lending Group and TransAct Technologies Incorporated
(incorporated by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K (SEC File No. 000-21121) filed with the SEC on July 26, 2021)
|
|
|
Amendment No. 2 To Loan and Security Agreement, dated as of July 19, 2022, between Siena Lending Group LLC and TransAct Technologies Incorporated
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (SEC File No. 000-21121) filed with the SEC on July 25, 2022).
|
|
|
Letter Amendment, dated May 1, 2023 (Amendment No. 3), to Loan and Security Agreement between Siena Lending Group LLC and TransAct Technologies
Incorporated (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (SEC File No. 000-21121) filed with the SEC on May 4, 2023).
|
|
|
Amendment No. 4 To Loan and Security Agreement, dated as of November 20, 2024, between Siena Lending Group LLC and TransAct Technologies
Incorporated (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (SEC File No. 000-21121) filed with the SEC on November 21,2024).
|
|
|
Second Amended and Restated Fee Letter, dated as of November 20, 2024, between Siena Lending Group LLC and TransAct Technologies Incorporated
(incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K (SEC File No. 000-21121) filed with the SEC on November 21, 2024).
|
|
|
Master License Agreement dated February 22, 2019 and amendments thereto (incorporated by reference to Exhibit 10.24 to the Company’s Annual Report
on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 12, 2021).
|
|
|
Master Development and License Agreement dated July 20, 2018 (incorporated by reference to Exhibit 10.25 to the Company’s Annual Report on Form 10-K
(SEC File No. 000-21121) filed with the SEC on March 12, 2021).
|
|
|
Lease Agreement by and between Constantino Noval Nevada 3, LLC and Transact Technologies Incorporated, dated February 9, 2026 (incorporated by
reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (SEC File No. 000-21121) filed with the SEC on February 13, 2026).
|
|
|
Source Code Purchase and Perpetual License Agreement, dated as of August 5, 2025 by and between TransAct Technologies Incorporated and Avery Dennison
Corporation (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (SEC File No. 000-21121) filed with the SEC on August 6, 2025).
|
|
|
19*
|
TransAct Technologies Incorporated Insider Trading Policy.
|
|
Subsidiaries of the Company (incorporated by reference to Exhibit 21 to the Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with
the SEC on March 12, 2021).
|
|
|
23.1*
|
Consent of CBIZ CPAs P.C.
|
|
23.2*
|
Consent of Marcum LLP.
|
|
31.1*
|
Rule 13a-14(a) Certification of Chief Executive Officer in accordance with Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
31.2*
|
Rule 13a-14(a) Certification of Chief Financial Officer in accordance with Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32‡
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
|
TransAct Technologies Incorporated Clawback Policy in the Event of a Financial Restatement (incorporated by reference to Exhibit 97 to the
Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 13, 2024).
|
|
|
101.INS
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the
Inline XBRL document).
|
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document.
|
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document.
|
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document.
|
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
104
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
|
| (x) |
Management contract or compensatory plan or arrangement.
|
| * |
These exhibits are filed herewith.
|
| † |
Certain portions of this exhibit (indicated by “[***]”) have been omitted pursuant to Item (601)(b)(10) of Regulation S-K.
|
| ‡ |
These exhibits are furnished herewith
|
| (b) |
Exhibits.
|
| (c) |
Financial Statement Schedules.
|
|
TRANSACT TECHNOLOGIES INCORPORATED
|
||
|
By:
|
/s/ John M. Dillon
|
|
|
Name:
|
John M. Dillon
|
|
|
Title:
|
Chief Executive Officer
|
|
|
Signature
|
Title
|
Date
|
||||
|
/s/ John M. Dillon
|
Chief Executive Officer and Director
|
March 12, 2026
|
||||
|
John M. Dillon
|
(Principal Executive Officer)
|
|||||
|
/s/ Steven A. DeMartino
|
President, Chief Financial Officer, Treasurer and Secretary
|
March 12, 2026
|
||||
|
Steven A. DeMartino
|
(Principal Financial Officer)
|
|||||
|
/s/ William J. DeFrances
|
Vice President and Chief Accounting Officer
|
March 12, 2026
|
||||
|
William J. DeFrances
|
(Principal Accounting Officer)
|
|||||
|
/s/ Haydee Ortiz Olinger
|
Chair of the Board
|
March 12, 2026
|
||||
|
Haydee Ortiz Olinger
|
||||||
|
/s/ Audrey P. Dunning
|
Director
|
March 12, 2026
|
||||
|
Audrey P. Dunning
|
||||||
|
/s/ Daniel M. Friedberg
|
Director
|
March 12, 2026
|
||||
|
Daniel M. Friedberg
|
||||||
|
/s/ Randall S. Friedman
|
Director
|
March 12, 2026
|
||||
|
Randall S. Friedman
|
||||||
|
/s/ Emanuel P. N. Hilario
|
Director
|
March 12, 2026
|
||||
|
Emanuel P. N. Hilario
|
|
Consolidated Financial Statements
|
||
|
F-2
|
||
|
|
F-4 | |
|
Consolidated Balance Sheets as of December 31, 2025 and 2024
|
F-5
|
|
|
Consolidated Statements of Operations for the years ended December 31, 2025 and 2024
|
F-6
|
|
|
Consolidated Statements of Comprehensive Loss for the years ended December 31, 2025 and 2024
|
F-7
|
|
|
Consolidated Statements of Changes in Shareholders’ Equity for the years ended December 31, 2025 and 2024
|
F-8
|
|
|
Consolidated Statements of Cash Flows for the years ended December 31, 2025 and 2024
|
F-9
|
|
|
F-10
|
| • |
Obtained an understanding of the Company’s accounting policy related to inventory, specifically as it relates to the excess and obsolete inventory
reserve and ensure it is relevant to the accounting standards and consistent applied to prior periods;
|
| • |
Recalculated the inventory reserve based on the Company’s policy and our knowledge obtained above. Ensure mathematical accuracy and test the
computations for a sample of inventory items;
|
| • |
Evaluated management’s methodology and process for developing the excess and obsolete inventory reserve, including estimating assumptions related
to future product demand based on historical usage and current market conditions;
|
| • |
Tested management’s calculation of the excess and obsolete inventory reserve, which included evaluating the completeness and accuracy of underlying
data used by management in the calculation, principally inputs such as actual usage and management’s determination of future estimated consumption of inventory and comparing them to historical amounts;
|
| • |
Performed observation of inventory at various Company locations to ensure the quantities are in working order and identify damaged or poor
conditioned inventory.
|
|
December 31,
2025
|
December 31,
2024
|
|||||||
|
Assets:
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Accounts receivable, net of allowance for expected credit losses of $
|
|
|
||||||
|
Inventories
|
|
|
||||||
|
Prepaid income taxes
|
|
|
||||||
|
Other current assets
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
Fixed assets, net of accumulated depreciation of $
|
|
|
||||||
|
Right-of-use assets, net
|
|
|
||||||
|
Goodwill
|
|
|
||||||
|
Intangible assets, net of accumulated amortization of $
|
|
|
||||||
|
Other assets
|
|
|
||||||
|
|
|
|||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
Liabilities and Shareholders’ Equity:
|
||||||||
|
Current liabilities:
|
||||||||
|
Revolving loan payable
|
$
|
|
$
|
|
||||
|
Accounts payable
|
|
|
||||||
|
Accrued liabilities
|
|
|
||||||
|
Lease liabilities
|
|
|
||||||
|
Deferred revenue
|
|
|
||||||
|
Total current liabilities
|
|
|
||||||
|
Deferred revenue, net of current portion
|
|
|
||||||
|
Lease liabilities, net of current portion
|
|
|
||||||
|
Other liabilities
|
|
|
||||||
|
|
|
|||||||
|
Total liabilities
|
|
|
||||||
|
Commitments and contingencies (see Notes 9 and 15)
|
||||||||
|
Shareholders’ equity:
|
||||||||
|
Preferred stock, $
|
|
|
||||||
|
Preferred stock, Series A, $
|
|
|
||||||
|
Common stock, $
|
|
|
||||||
|
Additional paid-in capital
|
|
|
||||||
|
Retained earnings
|
|
|
||||||
|
Accumulated other comprehensive loss, net of tax
|
(
|
)
|
(
|
)
|
||||
|
Treasury stock,
|
(
|
)
|
(
|
)
|
||||
|
Total shareholders’ equity
|
|
|
||||||
|
Total liabilities and shareholders’ equity
|
$
|
|
$
|
|
||||
|
Years Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Net sales
|
$
|
|
$
|
|
||||
|
Cost of sales
|
|
|
||||||
|
Gross profit
|
|
|
||||||
|
Operating expenses:
|
||||||||
|
Engineering, design and product development
|
|
|
||||||
|
Selling and marketing
|
|
|
||||||
|
General and administrative
|
|
|
||||||
|
|
|
|||||||
|
Operating loss
|
(
|
)
|
(
|
)
|
||||
|
Interest and other income (expense):
|
||||||||
|
Interest expense
|
(
|
)
|
(
|
)
|
||||
|
Interest income
|
|
|
||||||
|
Other, net
|
|
(
|
)
|
|||||
|
|
|
|||||||
|
Loss before income taxes
|
(
|
)
|
(
|
)
|
||||
|
Income tax expense
|
(
|
)
|
(
|
)
|
||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Net loss per common share:
|
||||||||
|
Basic
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Diluted
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Shares used in per-share calculation:
|
||||||||
|
Basic
|
|
|
||||||
|
Diluted
|
|
|
||||||
|
Years Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Foreign currency translation adjustment, net of tax
|
|
(
|
)
|
|||||
|
Comprehensive loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Common Stock
|
Additional
Paid-in
|
Retained
|
Treasury
|
Accumulated
Other
Comprehensive
|
Total
|
|||||||||||||||||||||||
|
Shares
|
Amount
|
Capital
|
Earnings
|
Stock
|
Loss
|
Equity
|
||||||||||||||||||||||
|
Balance, December 31, 2023
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|||||||||||||
|
Issuance of common stock on restricted stock units
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Relinquishment of stock awards and deferred stock units to pay withholding taxes
|
(
|
)
|
|
(
|
)
|
|
|
|
(
|
)
|
||||||||||||||||||
|
Share-based compensation expense
|
–
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Foreign currency translation adjustment, net of tax
|
–
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Net loss
|
–
|
|
|
(
|
)
|
|
|
(
|
)
|
|||||||||||||||||||
|
Balance, December 31, 2024
|
|
|
|
|
(
|
)
|
(
|
)
|
|
|||||||||||||||||||
|
Issuance of common stock on restricted stock units
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Relinquishment of stock awards and deferred stock units to pay withholding taxes
|
(
|
)
|
|
(
|
)
|
|
|
|
(
|
)
|
||||||||||||||||||
|
Share-based compensation expense
|
–
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Foreign currency translation adjustment, net of tax
|
–
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Net loss
|
–
|
|
|
(
|
)
|
|
|
(
|
)
|
|||||||||||||||||||
|
Balance, December 31, 2025
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|||||||||||||
|
Years Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Adjustments to reconcile net loss to net cash provided by operating activities:
|
||||||||
|
Share-based compensation expense
|
|
|
||||||
|
Depreciation and amortization
|
|
|
||||||
|
Deferred income taxes
|
|
|
||||||
|
Loss on disposal of fixed assets
|
||||||||
|
Foreign currency transaction (gains) losses
|
(
|
)
|
|
|||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
|
|
||||||
|
Inventories
|
|
|
||||||
|
Prepaid income taxes
|
|
(
|
)
|
|||||
|
Other current and long-term assets
|
|
(
|
)
|
|||||
|
Accounts payable
|
(
|
)
|
|
|||||
|
Accrued liabilities and other liabilities
|
|
(
|
)
|
|||||
|
Net cash provided by operating activities
|
|
|
||||||
|
Cash flows from investing activities:
|
||||||||
|
Capital expenditures
|
(
|
)
|
(
|
)
|
||||
|
Capitalized software development costs
|
( |
) | ||||||
|
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
||||
|
Cash flows from financing activities:
|
||||||||
|
Proceeds from bank borrowings
|
|
|
||||||
|
Withholding taxes paid on stock issuance
|
(
|
)
|
(
|
)
|
||||
|
Payment of bank financing costs
|
|
(
|
)
|
|||||
|
Net cash (used in) provided by financing activities
|
(
|
)
|
|
|||||
|
Effect of exchange rate changes on cash and cash equivalents
|
|
(
|
)
|
|||||
|
Increase in cash and cash equivalents
|
|
|
||||||
|
Cash and cash equivalents, beginning of period
|
|
|
||||||
|
Cash and cash equivalents, end of period
|
$
|
|
$
|
|
||||
|
Supplemental cash flow information:
|
||||||||
|
Interest paid
|
$
|
|
$
|
|
||||
|
Income taxes paid
|
|
|
||||||
|
Non-cash capital expenditures
|
|
|
||||||
|
Years Ended December 31,
|
||||||||
|
(In thousands)
|
2025
|
2024
|
||||||
|
Balance, beginning of period
|
$
|
|
$
|
|
||||
|
Additions charged to costs and expenses
|
|
|
||||||
|
Deductions
|
|
|
(
|
)
|
||||
| Foreign exchange and other | ||||||||
|
Balance, end of period
|
$
|
|
$
|
|
||||
|
Year Ended December 31, 2025
|
||||||||||||
|
(In thousands)
|
United States
|
International
|
Total
|
|||||||||
|
Food service technology
|
$
|
|
$
|
|
$
|
|
||||||
|
POS automation
|
|
|
|
|||||||||
|
Casino and gaming
|
|
|
|
|||||||||
|
TransAct Services Group
|
|
|
|
|||||||||
|
Total net sales
|
$
|
|
$
|
|
$
|
|
||||||
|
Year Ended December 31, 2024
|
||||||||||||
|
(In thousands)
|
United States
|
International
|
Total
|
|||||||||
|
Food service technology
|
$
|
|
$
|
|
$
|
|
||||||
|
POS automation
|
|
|
|
|||||||||
|
Casino and gaming
|
|
|
|
|||||||||
|
TransAct Services Group
|
|
|
|
|||||||||
|
Total net sales
|
$
|
|
$
|
|
$
|
|
||||||
|
December 31,
|
||||||||
|
(In thousands)
|
2025
|
2024
|
||||||
|
Unbilled receivables, current
|
$
|
|
$
|
|
||||
|
Unbilled receivables, non-current
|
|
|
||||||
|
Customer pre-payments
|
(
|
)
|
(
|
)
|
||||
|
Deferred revenue, current
|
(
|
)
|
(
|
)
|
||||
|
Deferred revenue, non-current
|
(
|
)
|
(
|
)
|
||||
|
Net contract liabilities
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Aristocrat Technologies, Inc.
|
|
%
|
|
%
|
||||
|
Light & Wonder Gaming, Inc.
|
|
%
|
|
%
|
||||
|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Light & Wonder Gaming, Inc.
|
% | % | ||||||
|
December 31,
|
||||||||
|
(In thousands)
|
2025
|
2024
|
||||||
|
Raw materials and purchased component parts
|
$
|
|
$
|
|
||||
|
Finished goods
|
|
|
||||||
|
$
|
|
$
|
|
|||||
|
December 31,
|
||||||||
|
(In thousands)
|
2025
|
2024
|
||||||
|
Tooling, machinery and equipment
|
$
|
|
$
|
|
||||
|
Furniture and office equipment
|
|
|
||||||
|
Computer software and equipment
|
|
|
||||||
|
Leasehold improvements
|
|
|
||||||
|
|
|
|||||||
|
Less: Accumulated depreciation and amortization
|
(
|
)
|
(
|
)
|
||||
|
|
|
|||||||
|
Construction in-process
|
|
|
||||||
|
$
|
|
$
|
|
|||||
|
December 31,
|
||||||||||||||||
|
2025
|
2024
|
|||||||||||||||
|
(In thousands)
|
Gross Amount
|
Accumulated Amortization
|
Gross Amount
|
Accumulated Amortization
|
||||||||||||
|
Purchased technology
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||
|
Patents
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Total
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||
|
December 31,
|
||||||||
|
(In thousands)
|
2025
|
2024
|
||||||
|
Salaries and compensation related
|
$
|
|
$
|
|
||||
|
Taxes
|
|
|
||||||
|
Professional and consulting
|
|
|
||||||
|
Other
|
|
|
||||||
|
$
|
|
$
|
|
|||||
|
December 31,
|
||||||||
|
(In thousands)
|
2025
|
2024
|
||||||
|
Revenues
|
$
|
|
$
|
|
||||
|
Cost of materials sold
|
|
|
||||||
|
Compensation costs
|
|
|
||||||
|
Professional services
|
|
|
||||||
|
Occupancy costs
|
|
|
||||||
|
Marketing expenses
|
|
|
||||||
|
IT expenses
|
|
|
||||||
|
Severance expense
|
|
|
||||||
|
Depreciation and amortization
|
|
|
||||||
|
Other segment expenses(1)
|
|
|
||||||
| Operating loss |
(
|
)
|
(
|
)
|
||||
|
Interest income
|
|
|
||||||
|
Interest expense
|
(
|
)
|
(
|
)
|
||||
|
Other income (expense)
|
|
(
|
)
|
|||||
|
Income tax expense
|
(
|
)
|
(
|
)
|
||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
| (1) |
|
|
Years Ended December 31,
|
||||||||
|
(In thousands)
|
2025
|
2024
|
||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Interest income, net
|
(
|
)
|
(
|
)
|
||||
|
Income tax expense
|
|
|
||||||
|
Depreciation and amortization
|
|
|
||||||
|
EBITDA
|
(
|
)
|
(
|
)
|
||||
|
Share-based compensation
|
|
|
||||||
|
Adjusted EBITDA
|
$
|
|
$
|
(
|
)
|
|||
|
Years ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Expected option term (in years)
|
–
|
|
||||||
|
Expected volatility
|
–
|
|
|
%
|
||||
|
Risk-free interest rate
|
–
|
|
|
%
|
||||
|
Dividend yield
|
–
|
|
|
%
|
||||
|
Stock Options
|
Restricted Stock Units
|
|||||||||||||||
|
Number
of Shares
|
Average Price*
|
Number
of Units
|
Average Price**
|
|||||||||||||
|
Outstanding at December 31, 2024
|
|
$
|
|
|
$
|
|
||||||||||
|
Granted
|
|
|
|
|
||||||||||||
|
Exercised
|
|
|
(
|
)
|
|
|||||||||||
|
Forfeited
|
(
|
)
|
|
(
|
)
|
|
||||||||||
|
Expired
|
(
|
)
|
|
|
|
|||||||||||
|
Outstanding at December 31, 2025
|
|
$
|
|
|
$
|
|
||||||||||
| * |
|
| ** |
|
|
Equity Awards Vested and Expected to Vest
|
Equity Awards That Are Exercisable
|
|||||||||||||||||||||||||||||||
|
Awards
|
Average Price*
|
Aggregate
Intrinsic
Value
(In thousands)
|
Remaining Term**
|
Awards
|
Average Price*
|
Aggregate
Intrinsic
Value
|
Remaining Term**
|
|||||||||||||||||||||||||
|
Stock Options
|
|
$
|
|
$
|
|
|
|
$
|
|
$
|
|
|
||||||||||||||||||||
|
Restricted stock units
|
|
|
|
|
–
|
–
|
–
|
–
|
||||||||||||||||||||||||
| * |
weighted average exercise price per share
|
| ** |
|
|
Year Ended December 31,
|
||||||||
|
(In thousands)
|
2025
|
2024
|
||||||
|
Domestic
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Foreign
|
|
|
||||||
|
Loss before income taxes
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
December 31,
|
||||||||
|
(In thousands)
|
2025
|
2024
|
||||||
|
Current:
|
||||||||
|
Federal
|
$
|
|
$
|
(
|
)
|
|||
|
State
|
|
|
||||||
|
Foreign
|
|
|
||||||
|
|
(
|
)
|
||||||
|
Deferred:
|
||||||||
|
Federal
|
|
|
||||||
|
State
|
|
|
||||||
|
Foreign
|
|
|
||||||
|
|
|
|||||||
|
Income tax expense
|
$
|
|
$
|
|
||||
|
December 31,
|
||||||||
|
(In thousands)
|
2025
|
2024
|
||||||
|
U.S. Federal
|
$
|
|
$
|
|
||||
|
State:
|
||||||||
|
Connecticut
|
|
|
||||||
|
Texas
|
|
|
||||||
|
New York
|
|
|
||||||
|
All other
|
|
|
||||||
|
State Subtotal
|
|
|
||||||
|
Foreign:
|
||||||||
|
United Kingdom
|
|
|
||||||
|
Foreign Subtotal
|
|
|
||||||
|
Total cash paid for income taxes, net of refunds
|
$
|
|
$
|
|
||||
|
December 31,
|
||||||||
|
(In thousands)
|
2025
|
2024
|
||||||
|
Deferred tax assets:
|
||||||||
|
Federal net operating losses
|
$
|
|
$
|
|
||||
|
Foreign net operating losses
|
|
|
||||||
|
State net operating losses
|
|
|
||||||
|
Accrued severance
|
|
|
||||||
|
Capitalized R&D expenses
|
|
|
||||||
|
Inventory reserves
|
|
|
||||||
|
Deferred revenue
|
|
|
||||||
|
Warranty reserve
|
|
|
||||||
|
Stock compensation expense
|
|
|
||||||
|
Other accrued compensation
|
|
|
||||||
|
R&D credit carryforward
|
|
|
||||||
|
Other Assets
|
||||||||
|
Gross deferred tax assets
|
|
|
||||||
|
Valuation allowance
|
(
|
)
|
(
|
)
|
||||
|
Net deferred tax assets
|
|
|
||||||
|
Deferred tax liabilities:
|
||||||||
|
Depreciation and amortization
|
|
|
||||||
|
Other
|
|
|
||||||
|
Net deferred tax liabilities
|
|
|
||||||
|
Total net deferred tax assets
|
$
|
|
$
|
|
||||
|
Year Ended December 31,
|
||||||||
|
(In thousands)
|
2025
|
2024
|
||||||
|
Balance, beginning of period
|
$
|
|
$
|
|
||||
|
Additions charged to income tax provision
|
|
|
||||||
|
Balance, end of period
|
$
|
|
$
|
|
||||
|
2025
|
2024
|
|||||||||||||||
|
(Dollars in thousands)
|
$ |
% | $ |
% | ||||||||||||
|
Loss before income taxes
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||||||
|
U.S. Federal Statutory Tax Rate
|
(
|
)
|
|
%
|
(
|
)
|
|
%
|
||||||||
|
Current State and Local Income Taxes, net of Federal Income Tax Effect
|
|
(
|
%)
|
(
|
)
|
|
%
|
|||||||||
|
Foreign Tax Effects
|
||||||||||||||||
|
United Kingdom – statutory rate differences
|
(
|
)
|
|
|
(
|
%)
|
||||||||||
|
Macau – change in valuation allowance
|
( |
%) | ||||||||||||||
|
Effect of changes in Tax Laws or Rates Enacted in the Current Period
|
|
|
|
|
||||||||||||
|
Effect of Cross-Border Tax Laws
|
|
|
|
|
||||||||||||
|
Tax Credits
|
(
|
)
|
|
%
|
(
|
)
|
|
%
|
||||||||
|
Nontaxable or Nondeductible Items
|
||||||||||||||||
|
Share based payment awards
|
|
(
|
%)
|
|
(
|
%)
|
||||||||||
|
Stock Option cancellations
|
|
(
|
%)
|
|
(
|
%)
|
||||||||||
|
Meals and entertainment
|
( |
%) | ||||||||||||||
|
Changes in Valuation Allowance
|
|
(
|
%)
|
|
(
|
%)
|
||||||||||
|
Other Adjustments
|
||||||||||||||||
|
Resolution of uncertain tax positions
|
( |
) | % | |||||||||||||
|
Net operating losses
|
( |
%) | ||||||||||||||
|
Research and development credit carryforward
|
( |
) | % | |||||||||||||
|
Other
|
( |
%) | ( |
) | % | |||||||||||
|
Effective Tax Rate
|
$
|
|
(
|
%)
|
$
|
|
(
|
%)
|
||||||||
|
December 31,
|
||||||||
|
(In thousands)
|
2025
|
2024
|
||||||
|
Balance, beginning of period
|
$
|
|
$
|
|
||||
|
Tax positions taken during the current period
|
|
|
||||||
| Reductions for tax positions in prior years |
( |
) | ( |
) | ||||
|
Balance, end of period
|
$
|
|
$
|
|
||||
|
Years Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Shares:
|
||||||||
|
Basic: Weighted average common shares outstanding
|
|
|
||||||
|
Add: Dilutive effect of outstanding equity awards as determined by the treasury stock method
|
|
|
||||||
|
Diluted: Weighted average common and common equivalent shares outstanding
|
|
|
||||||
|
Net loss per common share:
|
||||||||
|
Basic
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Diluted
|
(
|
)
|
(
|
)
|
||||
|
Years Ended December 31,
|
||||||||
|
(In thousands)
|
2025
|
2024
|
||||||
|
Net sales:
|
||||||||
|
United States
|
$
|
|
$
|
|
||||
|
International
|
|
|
||||||
|
Total
|
$
|
|
$
|
|
||||
|
Fixed assets, net:
|
||||||||
|
United States
|
$
|
|
$
|
|
||||
|
International
|
|
|
||||||
|
Total
|
$
|
|
$
|
|
||||
|
Years Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Operating cash outflows from leases
|
$
|
|
$
|
|
||||
|
Years Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Weighted average remaining lease term (in years)
|
|
|
||||||
|
Weighted average discount rate
|
|
%
|
|
%
|
||||
|
December 31, 2025
|
||||
|
2026
|
$
|
|
||
|
2027
|
|
|||
| 2028 | ||||
| Thereafter |
||||
|
Total undiscounted lease payments
|
|
|||
|
Less imputed interest
|
|
|||
|
Total lease liabilities
|
$
|
|
||
|
Quarter Ended
|
||||||||||||||||
|
(In thousands, except per share amounts)
|
March 31
|
June 30
|
September 30
|
December 31
|
||||||||||||
|
2025:
|
||||||||||||||||
|
Net sales
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Gross profit
|
|
|
|
|
||||||||||||
|
Net income (loss)
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Net income (loss) per common share:
|
||||||||||||||||
|
Basic
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Diluted
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
2024:
|
||||||||||||||||
|
Net sales
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Gross profit
|
|
|
|
|
||||||||||||
|
Net loss
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Net loss per common share:
|
||||||||||||||||
|
Basic
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Diluted
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
| 1. |
PURPOSE
|
| 2. |
INDIVIDUAL RESPONSIBILITY
|
| 3. |
STATEMENT OF GENERAL POLICY
|
| • |
This Policy applies to all transactions in the Company’s securities, including, without limitation, common stock, preferred stock and debt securities, as well as
transactions in the securities of the Company’s customers and other companies with which the Company has business relationships, as applicable (collectively, “Securities”).
|
| • |
It is not possible to define all categories of “material”
information. There is no bright-line standard for assessing materiality; rather, materiality is based on an assessment of all of the facts and circumstances and is often evaluated by enforcement authorities with the benefit of hindsight.
However, information should generally be regarded as material if: (i) there is a substantial likelihood that a reasonable investor would consider it important in making an investment decision, or (ii) the information is reasonably certain to
have a substantial effect on the price of a company’s securities.
|
| • |
Information is considered “nonpublic” if it has not been
disseminated in a manner making it available to investors generally, such as through disclosure in an annual, quarterly or current report filed with the Securities and Exchange Commission (the “SEC”), inclusion in a press release, or wide reporting in the media, and until investors have had a reasonable period of time to react to the information. Generally, information should not
be considered fully absorbed by the marketplace until two (2) full trading days have passed after the day on which the information is released.
|
| • |
In accordance with federal law, this Policy prohibits Covered Persons from trading in Securities while in possession of MNPI relating to the Company, which is also known
as “inside information.”
|
| • |
Any Covered Person who is unsure whether the information that such Covered Person possesses is material or nonpublic should consult the Chief Financial Officer of the
Company for guidance before trading in any Securities.
|
| 4. |
APPLICABILITY OF POLICY
|
| • |
In addition to all Covered Persons, this Policy also applies to family members who reside in a Covered Person’s household (including a spouse, a child away at college,
stepchildren, grandchildren, parents, stepparents, grandparents, siblings and in-laws), anyone else who lives in a Covered Person’s household, and any family members who do not live in a Covered Person’s household but whose transactions in
Securities are directed by a Covered Person or are subject to a Covered Person’s influence or control, such as parents or children who consult with a Covered Person before they trade in Securities. Covered Persons are responsible for
transactions in Securities by these other individuals and therefore should make them aware of the need to confer with such Covered Persons before they trade in Securities, and each such Covered Person should treat all such transactions for
purposes of this Policy and applicable securities laws as if they were for such Covered Person’s own account.
|
| • |
This Policy applies to any entities that a Covered Person influences or controls, including any corporations, partnerships or trusts (collectively referred to as “Controlled Entities”), and transactions by these Controlled Entities should be treated for purposes of this Policy and applicable securities
laws as if they were for such Covered Person’s own account.
|
| • |
This Policy (including Section 6 hereof) establishes additional procedures, requirements and rules that apply to (1) Directors, (2) Officers of the Company who are
“executive officers” for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), who are referred
to collectively in this Policy as “Designated Officers” and each a “Designated Officer,” and (3) Covered Persons who have access to confidential business and financial information about the Company, including, without limitation, employees and consultants working in or with
the Company’s finance group (“Inside Employees/Consultants”).
|
| • |
This Policy and the guidelines described herein also apply to MNPI relating to other companies, including, but not limited to, (1) the Company’s customers, vendors,
suppliers and other related parties, (2) companies that are involved in a potential transaction or business relationship with the Company, and (3) other public companies (including if MNPI about the Company may have a significant impact on
such other company), when that information is obtained in the course of employment with, or other services performed on behalf of, the Company. All persons subject to this Policy must avoid trading in securities of customers, vendors,
suppliers and other related parties using MNPI received from such parties.
|
| • |
This Policy prohibits the disclosure and dissemination of MNPI about a company, either within or outside the Company, except on a reasonable need-to-know basis that
furthers a legitimate business purpose of such company or the Company. Unlawfully disclosing or “tipping” MNPI about a company to others, who then trade while in possession of MNPI, may give rise to claims against the “tipper” of the
information.
|
| • |
This Policy will continue to apply to former and retired Directors and Designated Officers until the later of: (i) the expiration of two (2) full trading days after any
MNPI known to such persons has become public or is no longer material; and (ii) the expiration of ninety (90) calendar days following termination of service with the Company.
|
| 5. |
CERTAIN EXCEPTIONS TO THE POLICY
|
| • |
Certain Stock Option Exercises. This Policy does not apply to the exercise of a stock option acquired pursuant to the Company’s equity plans, including the withholding of shares of stock to satisfy the
exercise price of an option or tax withholding obligations that do not involve market transactions in Company securities. However, this Policy does apply
to broker-assisted cashless exercises of stock options and to any other market sale (whether of the purchased option shares or other shares owned by the Covered Person) for the purpose of generating the cash needed to pay the exercise price of
an option or to pay taxes.
|
| • |
Pre-Existing/10b5-1 Trading Plans. Notwithstanding the general
prohibition set forth above, a Covered Person may effect transactions in Securities during a Blackout Period (as defined in Section 6 of this Policy), or at a time when the Covered Person is in possession of MNPI, if such transactions are
pursuant to a trading program that complies with the requirements of Rule 10b5-1 under the Exchange Act. Rule 10b5-1 under the Exchange Act provides a defense from insider trading liability under Rule 10b-5. In order to be eligible to rely on
this defense, a Covered Person must enter into a Rule 10b5-1 plan for transactions in Securities that meets certain conditions specified in the Rule (a “Rule 10b5‑1 Plan”). If the plan meets the requirements of Rule 10b5-1, transactions in Securities may occur even when the person who has entered into the plan is aware of MNPI. To comply with this Policy, a Rule 10b5-1 Plan
must be approved by the Chief Financial Officer and meet the requirements of Rule 10b5-1, as generally set forth below:
|
| o |
A Rule 10b5-1 Plan must be entered into at a time when the person entering into the plan is not aware of MNPI.
|
| o |
Once the plan is adopted, the person must not exercise any influence over the amount of securities to be traded, the price at which they are to be traded or the date of
the trade. The plan must either specify the amount, pricing and timing of transactions in advance or a formula to make such determinations or delegate discretion on these matters to an independent third party.
|
| o |
The plan must include a cooling-off period after the plan is adopted before trading can commence that, for Directors and Designated Officers, ends after the later of 90
days after the adoption of the Rule 10b5-1 Plan and two business days following the disclosure of the Company’s financial results in an SEC periodic report for the fiscal quarter in which the plan was adopted (but in any event, the required
cooling-off period is subject to a maximum of 120 days after adoption of the plan), and for persons other than Directors and Designated Officers, 30 days following the adoption or modification of a Rule 10b5-1 Plan.
|
| o |
A person may not enter into overlapping Rule 10b5-1 Plans (subject to certain exceptions) and may only enter into one single-trade Rule 10b5-1 Plan during any 12-month
period (subject to certain exceptions).
|
| o |
A Director or Designated Officer must include a representation in the Rule 10b5-1 Plan certifying that such person is: (i) not aware of any MNPI; and (ii) adopting the
Rule 10b5-1 Plan in good faith and not as part of a plan or scheme to evade the prohibitions in Rule 10b-5.
|
| o |
Each person entering into a Rule 10b5-1 Plan must act in good faith with respect to that plan.
|
| • |
Tax Withholding by the Company. This Policy does not apply to the withholding of stock to pay applicable withholding taxes upon the vesting of restricted stock, restricted stock units or other equity
awards. However, Securities may not be sold to satisfy tax obligations during a Blackout Period, or while the participant is in possession of MNPI,
absent an approved Rule 10b5-1 Plan.
|
| • |
401(k) Plan. This Policy does not apply to purchases of Securities in a Company 401(k) Plan resulting from a Covered Person’s periodic contribution of money to the plan pursuant to his or her payroll deduction
election. This Policy does apply, however, to certain elections a Covered Person may make under such a Company 401(k) Plan, including: (i) an election
to increase the percentage of his or her periodic contributions that will be allocated to his or her Company stock account; (ii) an election to make an intra-plan transfer of an existing account balance into or out of his or her Company stock
account; and (iii) any transaction that would result in the liquidation of some or all of his or her Company stock account balance.
|
| • |
Employee Stock Purchase Plan. Purchases of Securities under any
Company employee stock purchase plan, through periodic contributions to the plan in accordance with an election made by a Covered Person at enrollment. However, a Covered Person may not elect to participate in such a plan for any enrollment
period during a Blackout Period. This Policy also applies to any open market sales of Securities purchased pursuant to such a plan by a Covered Person.
|
| • |
Dividend Reinvestment Plan. Purchases of Securities under any
Company dividend reinvestment plan that results from a Covered Person’s reinvestment of dividends paid on Securities. However, voluntary purchases of Securities resulting from additional contributions a Covered Person makes to a Company
dividend reinvestment plan, and to such Covered Person’s election to participate in such plan, or increase the level of participation in such plan, are subject to
this Policy. This Policy also applies to open market sales by a Covered Person of Securities purchased pursuant to a dividend
reinvestment plan.
|
| • |
Other Similar Transactions. Any other purchase of Securities
from the Company or sales of Securities to the Company, or any private transaction in Securities solely between Directors and/or Officers who have access to, or are aware of, the same MNPI are not subject to this Policy.
|
| • |
Bona fide gifts. Bona fide gifts of Securities are not transactions subject to any part of this Policy other than the pre-approval and pre-clearance requirement set forth in Section 6 under the heading
“Pre-Approval & Pre-Clearance of Transactions in and Gifts of Securities,” below, unless the person making the gift knows or has reason
to believe that the recipient intends to sell the Securities while the Covered Person is aware of MNPI.
|
| 6. |
TRADING RESTRICTIONS AND PROCEDURES
|
| • |
Pre-Approval & Pre-Clearance of Transactions in and Gifts of
Securities. Any transaction in or gift of Securities by a Director, Designated Officer or Inside Employee/Consultant (as defined in Section 4 of this Policy), must be pre-approved and pre-cleared by the Chief Financial Officer of the
Company, or such other officer of the Company as the Chief Financial Officer may designate from time to time.
|
| • |
Blackout Periods. Directors, Designated Officers and Inside
Employees/Consultants are prohibited from trading in Securities from the date that is fifteen (15) calendar days prior to the close of each fiscal quarter or year through the expiration of the second (2nd) full trading day following the date of
public disclosure of the Company’s financial performance and results of operations for that fiscal quarter or year (the “Blackout Period”).
Additional Blackout Periods may be imposed on such persons and certain or all other Covered Persons at such times as deemed appropriate by management or the Board of Directors of the Company (the “Board”). Due to the confidential nature of the circumstances that may trigger such event-specific Blackout Periods, the reason for the Blackout Period may not be disclosed and the
existence of the Blackout Period may be considered MNPI and, therefore, should not be shared.
|
| • |
Window Periods. Any transaction by a Director, Designated Officer
or Inside Employee/Consultant that has been pre-approved and pre-cleared shall be effected only during the period of time designated for trading by the Company. “Window Periods” will commence after the second (2nd) full trading day following the release of the Company’s financial performance and results of operations for each fiscal quarterly or annual period, and will
continue until fifteen (15) calendar days prior to the close of the next fiscal quarterly or annual period, unless management or the Board imposes a Blackout Period covering such period, or any portion thereof, in which case the Window Period
will not open or will close earlier than in accordance with such schedule, as determined by management or the Board.
|
| • |
Material Nonpublic Information. Any Covered Person possessing MNPI
concerning the Company, even if during a Window Period, should not engage in any transactions in Securities until such MNPI has been known publicly for at least two (2) full trading days, whether or not the Company has recommended a suspension
of trading to that person, or until such information otherwise ceases to constitute MNPI.
|
| • |
Section 16. Directors and Designated Officers are subject to the
reporting and short swing profit recovery provisions of Section 16 of the Exchange Act and must comply with the applicable reporting requirements under the Exchange Act and avoid engaging in short swing transactions, whether or not in
possession of MNPI, and whether or not such transactions would be deemed to result in a short swing profit. A “short swing” transaction means a sale of Company Securities in the open market during the six months following an open-market
purchase of the same class of Company Securities or an open-market purchase during the six months following an open-market sale.
|
| 7. |
PROHIBITED TRANSACTIONS
|
| • |
Short Sales. Covered Persons may not engage in short sales of
Company Securities (i.e., sales of Company Securities that the seller does not own), including a “sale against the box” (i.e., a short sale where the seller owns the Securities but delays delivery, i.e., retains both the short and long
positions).
|
| • |
Publicly Traded Options. Covered Persons may not engage in
speculative trading, including transactions in publicly traded options of the Company, such as puts, calls, warrants, and other derivative securities, on an exchange or in any other organized market.
|
| • |
Hedging or Monetization Transactions. No Covered Person is
permitted to enter into any hedging transaction with respect to Company Securities, including, but not limited to, the purchase or use of, directly or indirectly through any other persons or entities, any stock option, prepaid variable forward
contracts, equity swaps, collars, exchange funds or any other instruments designed to offset any decrease in the market value of Company Securities.
|
| • |
Margin Accounts and Pledging of Company Securities. Covered
Persons may not pledge any of the Company Securities owned by them. Company Securities held in a margin account or pledged as collateral for a loan may be sold without a Covered Person’s consent by the broker, if such Covered Person fails to
meet a margin call, or by the lender in foreclosure, if such Covered Person defaults on the loan, and may occur at a time when a Covered Person is aware of MNPI or otherwise is not permitted to trade in Company Securities. As a result, no
Covered Person may place Company Securities in margin accounts, unless the margin accounts are treated as non-marginable by the brokerage firm.
|
| • |
Standing and Limit Orders. Standing and limit orders (except
standing and limit orders under approved Rule 10b5-1 Plans, as described above) create heightened risks for insider trading violations similar to the use of margin accounts. There is no control over the timing of purchases or sales that result
from standing instructions to a broker, and as a result the broker could execute a transaction when a Covered Person is in possession of material nonpublic information. The Company therefore discourages placing standing or limit orders on
Company Securities. If a person subject to this Policy determines that they must use a standing order or limit order, the order should be limited to short duration and should otherwise comply with this Policy.
|
| • |
No Tipping. Covered Persons may not pass MNPI on to others or
recommend to anyone the purchase or sale of any Securities when aware of such information. This practice is known as “tipping” and violates the federal securities laws, even if a Covered Person did not trade or gain any benefit from another
person’s trading.
|
| • |
Post-Termination Transactions. If a Covered Person is aware of
MNPI at the time such person ceases to be employed by or provide services to the Company, such Covered Person may not trade in Securities until such information has become public or is no longer material. As noted above, former and retired
Directors and Designated Officers continue to be subject to this Policy until the later of: (i) the expiration of two (2) full trading days after any MNPI known to such persons has become public or is no longer material; and (ii) the expiration
of ninety (90) calendar days following termination of service with the Company.
|
| 8. |
PENALTIES
|
| 1. |
I have reviewed this Annual Report on Form 10-K of TransAct Technologies Incorporated;
|
| 2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
| 3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
| 4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
| (a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
| (b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
| (c) |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
| (d) |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the
registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
| 5. |
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's
auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
| (a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
affect the registrant's ability to record, process, summarize and report financial information; and
|
| (b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial
reporting.
|
|
/s/ John M. Dillon
|
|
|
John M. Dillon
|
|
|
Chief Executive Officer
|
| 1. |
I have reviewed this Annual Report on Form 10-K of TransAct Technologies Incorporated;
|
| 2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
| 3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
| 4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
| (a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
| (b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
| (c) |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
| (d) |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the
registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
| 5. |
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's
auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
| (a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
affect the registrant's ability to record, process, summarize and report financial information; and
|
| (b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial
reporting.
|
|
/s/ Steven A. DeMartino
|
|
|
Steven A. DeMartino
|
|
|
President, Chief Financial Officer, Treasurer and Secretary
|
| (1) |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
| (2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
/s/ John M. Dillon
|
|
|
John M. Dillon
|
|
|
Chief Executive Officer
|
|
/s/ Steven A. DeMartino
|
|
|
Steven A. DeMartino
|
|
|
President, Chief Financial Officer, Treasurer and Secretary
|